Neuromod Closes €10M Financing
Summary
The coompany intends to use the funds to accelerate commercialisation for Lenire in the USA and Europe. Founded in 2010 by Dr. Ross O’Neill PhD, CEO, Neuromod Devices is a medical technology company which specialises in the design, development, and commercialisation of neuromodulation technologies to address the clinical needs of underserved patient populations who live with chronic and debilitating conditions. The lead application of Neuromod’s technology is tinnitus treatment device Lenire. Neuromod has been making Lenire available through audiology and ENT practices throughout the USA and Europe. Following FDA approval in March 2023, more than 100 clinics throughout the USA now treat tinnitus patients with Lenire.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected